Funcional Services Provider
One team, one goal, The Patient.
We generate solutions that guarantee compliance with deadlines and budgets. Our strong reputation is built on a long-standing commitment to quality and transparency.
We believe in the power of partnership. Our mission is to pursue breakthroughs in our drug treatment development to aid our patients and clients. We aspire to identify and track areas of improvement to support our patients and their families
Our services include
PATIENT RECRUITMENT
BRCR completed 2,311 clinical trials using the BRCR Full-Start Up Process™. This method fosters a culture of collaboration and excellence, ensuring swift, high-quality trial execution, and enhanced stakeholder coordination.
START-UP FOR STUDY INITIATION
Information gathering in countries of interest, site selection, regulatory process, budget and negotiation, and site visit initiation.
REGULATORY SOLUTIONS / LEGAL REPRESENTATION
Approvals from Ministries of Health and Ethics Committee.
CLINICAL OPERATIONS AND MONITORING
Project management, clinical monitoring, and maintenance of investigator site folder/trial master file.
SAFETY AND MEDICAL AFFAIRS
Critical follow-up and medical oversight to ensure integrity and safety of subjects and compliance with regional regulations.
LOGISTICS AND IMPORT SUPPORT
Importation of clinical trial materials with logistics solutions tailored to LATAM needs.
SUPPLIER MANAGEMENT
Selection, coordination, and supervision of suppliers to optimize the efficiency and quality of the study.
Oncology Expertise
Proven Oncology Leadership Across Latam
Her2 Negative Breast Cancer (Phase 3)
Services Provided: Start-up Solutions, Regulatory Submissions, Patient Recruitment Strategy, Project Management, Vendor Management, CTA and Budget Negotiation.
Outcome: Enrolled 190 patients across 60 sites in 12 countries in Mexico, Guatemala, Honduras, Costa Rica, Ecuador, Paraguay, Panama, Jamaica, Dominican Republic, Peru, Brazil, and Colombia.
Relapsed / Refractory Solid Tumors (Phase I)
- Services Provided: Regulatory Submissions, Site Selection (45 sites), Patient Recruitment, Project Management, Logistics, CTA Negotiation.
- Outcome: Achieved 140 enrollments with efficient regulatory approvals in 9 countries.
Lung Cancer Diagnostics Validation
- Services Provided: Start-Up, Regulatory Submissions, Recruitment Strategies, Monitoring, Logistics Coordination.
- Outcome: Enrolled 1056 subjects (exceeding the 800 target) across 12 sites in Peru.
A Phase 3 Breast Cancer Study (Epoetin Alfa)
- Services Provided: Regulatory submission, Patient Recruitment, Logistics in Ecuador.
- Outcome: 2098 patients enrolled globally.
Balstilimab for Recurrent Cervical Cancer (Phase 3)
- Services Provided: Regulatory Submissions, Patient Engagement, Site Activation.
- Outcome: High compliance and timely recruitment in Ecuador.
Non-Oncology Expertise
Expertise Diverse Therapeutic Expertise In Latam
Sickle Cell Disease (Phase 2/3)
Services Provided: Start-Up and regulatory services in Colombia.
Systemic Lupus Erythematosus (Phase 3)
- Services Provided: Comprehensive trial support, including regulatory submission, site selection, training, and monitoring in Ecuador.
- Outcome: Enrolled 1124 globally.
COVID-19 Vaccine Study (Adults)
- Services Provided: Site Selection, Training, Patient Recruitment, Monitoring, and Project Management.
- Outcome: Randomized 1055 participants in Queretaro, Mexico, delivering on recruitment targets within deadlines.
Subcutaneous LY2127399 in SLE (Phase 3b)
- Services Provided: End-to-end clinical management and regulatory oversight.
- Outcome: 1518 Enrolled globally. Successfully completed study phases in Ecuador with high data quality.
Balstilimab for Recurrent Cervical Cancer (Phase 3)
- Services Provided: Regulatory Submissions, Patient Engagement, Site Activation.
- Outcome: High compliance and timely recruitment in Ecuador.
Summary of Our Research Center Network connections for CRO
Research Center Network and Connections
82
Oncology Sites
384
Non-Oncology Sites
466
Total Sites
Research sites by Therapeutic Area
Dermatology
Endocrinology
Inmunology
Internal Medicine
Oncology
Orthopedic
Pediatrics
Pneumology
Urology
Cardiology
Rheumatology
Hematology
Infectology
Nephrology
Gastroenterology
Gynecology
Neurology
Ophthalmology
Why Choose BRCR?
Unlock LATAM’s Clinical Research Potential with BRCR Global
Efficiency and Compliance
> Proven 35% reduction in initiation timelines.
> 95% protocol adherence and 15% improvement in completion rates.
Expertise
> Decades of experience in Phase I-IV trials across oncology and non-oncology indications..
> Deep connections with KOLs, leading investigators, and regulatory authorities.
Cost-Effectiveness
> Local experts ensuring cost savings without compromising quality.
Flexibility
> Service models adapted to sponsor requirements.
> Multilingual team proficient in English and local languages.
Results-Oriented
> 10+ years of regional experience delivering high- quality outcomes across LATAM.
Ethic Solutions + Proactivity + Quality + Recruitment Results = Reduced Time
Our job is to collaborate as a true extension of your team, delivering a reduced regulatory process while selecting the right Investigators, monitoring with the highest quality, being proactive during the regulatory agencies processes, and representing you in a professional, scientific, ethical, and socially responsible way in each country.